ARIXTRA - 54868-5501-0 - (fondaparinux sodium)

Alphabetical Index


Drug Information of ARIXTRA

Product NDC: 54868-5501
Proprietary Name: ARIXTRA
Non Proprietary Name: fondaparinux sodium
Active Ingredient(s): 7.5    mg/.6mL & nbsp;   fondaparinux sodium
Administration Route(s): SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of ARIXTRA

Product NDC: 54868-5501
Labeler Name: Physicians Total Care, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021345
Marketing Category: NDA
Start Marketing Date: 20041117

Package Information of ARIXTRA

Package NDC: 54868-5501-0
Package Description: 10 SYRINGE in 1 CARTON (54868-5501-0) > .6 mL in 1 SYRINGE

NDC Information of ARIXTRA

NDC Code 54868-5501-0
Proprietary Name ARIXTRA
Package Description 10 SYRINGE in 1 CARTON (54868-5501-0) > .6 mL in 1 SYRINGE
Product NDC 54868-5501
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name fondaparinux sodium
Dosage Form Name INJECTION, SOLUTION
Route Name SUBCUTANEOUS
Start Marketing Date 20041117
Marketing Category Name NDA
Labeler Name Physicians Total Care, Inc.
Substance Name FONDAPARINUX SODIUM
Strength Number 7.5
Strength Unit mg/.6mL
Pharmaceutical Classes Factor Xa Inhibitor [EPC],Factor Xa Inhibitors [MoA]

Complete Information of ARIXTRA


General Information